# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

A. 510(k) Number: k092978   
B. Purpose for Submission: Device modification to k081830. New imaging aid to the existing device.   
C. Manufacturer and Instrument Name: Phadia AB, ImmunoCAP $\textsuperscript { \textregistered }$ Rapid Reader   
D. Type of Test or Tests Performed: Semi-quantitative, lateral flow immunoassay   
E. System Descriptions: 1. Device Description: The ImmunoCAP $\textsuperscript { \textregistered }$ Rapid Reader is part of ImmunoCAP $\textsuperscript { \textregistered }$ Rapid System, which is a combination of lateral flow immunoassay reagents and instrument/software for semi-quantitative determination of IgE antibodies in human capillary whole blood, heparinized venous whole blood or heparinized plasma. The Rapid Reader is a stand alone instrument to be used with ImmunoCAP Rapid Assay Device. It consists of the Rapid Reader instrument and associated software. The user interface consists of a LCD display with a touch screen and a slot for insertion of the ImmunoCAP Rapid Assay Device. The Reader includes functions for photometric reading and scoring of the test results. The Assay Device is illuminated with white color spectrum LED’s. A sensor records an image of the Assay Device including Test and Control Windows, and reads the color saturation (Color Units).

Software: The built in software performs the control checks and the necessary calculations to convert Color Units to Class scores. Patient or external control results are displayed and printed only if internal Reader controls and Assay Device controls are valid.

Assay Device docking system: The slot for the ImmunoCAP Rapid Assay Device has one optical switch for interaction with the Assay Device to initiate reading and system checks.

Camera, optics, and light source: The camera is a CMOS camera with a pixel resolution of $2 0 4 8 \mathrm { ~ x ~ } 1 5 3 6$ . The light source consists of four, white color spectrum LEDs placed behind four diffusers, to ensure even illumination of the reading area on the Assay Device.

Computer system and power supply: Integrated microprocessor with a 45W input $1 0 0 { - } 2 4 0 \mathrm { V } \sim 1 . 2 \mathrm { A } ~ 5 0 { - } 6 0 ~ \mathrm { H z }$ power supply.

Display and touch screen: The user interface consists of a LCD panel with $4 8 0 \mathrm { x }$ 272 pixel resolution, with included touch interface functionality.

Printer: Built in thermal printer for automatic printing of assay results.

2. Principles of Operation:

The Reader includes functions for photometric reading and scoring of the test results. The Assay Device is illuminated with white color spectrum LED’s. A sensor records an image of the Assay Device including Test and Control Windows, and reads the color saturation (Color Units). The built in software performs the control checks and the necessary calculations to convert Color Units to Class scores. Patient or external control results will be displayed and printed only if internal Reader controls and Assay Device controls are valid.

The ImmunoCAP Rapid Reader quantitatively measures the color saturation and converts the signal into Color Units (CU). The higher the concentration of IgE antibodies in the sample the stronger the color of the red lines, i.e. higher CU values. CU values are then categorized semiquantitatively into Class 1, 2 or 3. The user performs the Rapid assay according to the instructions for use and inserts the Assay Device into the Rapid Reader as shown on the screen of the Reader. If the necessary control conditions are met, assay results will be displayed on the screen and automatically printed. If the Reader does not detect the blood sample or the assay control lines are missing, the Rapid Reader will not report or print any results. The Reader displays results as Class 1, 2 or 3 for each allergen.

3. Modes of Operation: Semi-automated. No change from the predicate device.

4. Specimen Identification:

Manual input by user.. No changes from the Predicate Device.

5. Specimen Sampling and Handling:

Samples should be obtained and handled according to the laboratory’s standard operating procedures and following the protocol described in the package insert. No changes from the Predicate Device.

6. Calibration: ImmunoCAP Rapid Reader is calibrated at manufacturing and does not require any user calibration. No changes from the Predicate Device.

7. Quality Control: The performance of ImmunoCAP Rapid Reader is verified at regular intervals through the use of the Check Device. No changes from the Predicate Device.

8. Software: FDA has reviewed applicant’s Hazard Analysis and Software Development processes for this line of product types: Yes__X___ or No_

# F. Regulatory Information:

1. Regulation section: 21 CFR $\$ 866.5750$ , Radioallergosorbent (RAST) immunological test system

2. Classification: Class II

3. Product code: DHB System, Test, Radioallergosorbent (RAST), Immunological

4. Panel: Immunology (82)

# G. Intended Use:

1. Indication(s) for Use: ImmunoCAP Rapid Reader, part of ImmunoCAP Rapid System, is an instrument including software to be used for reading and scoring ImmunoCAP Rapid assay results. It is intended for in vitro diagnostic use and is to be used in clinical laboratories, licensed under CLIA to perform non-waived assays.

2. Special Conditions for Use Statement(s): For prescription only

# H. Substantial Equivalence Information:

1. Predicate Device Name(s) and 510(k) numbers: ImmunoCAP Rapid Reader, k081830

2. Comparison with Predicate Device:

<table><tr><td colspan="3">Similarities</td></tr><tr><td>Item</td><td>Device</td><td>Predicate</td></tr><tr><td>Intended Use System Configuration</td><td>ImmunoCAP Rapid Reader, part of ImmunoCAP Rapid System, is an instrument including software to be used for reading and scoring ImmunoCAP Rapid assay results. It is intended for in vitro diagnostic use and is to be used in clinical laboratories, licensed under CLIA to perform non-waived assays. ImmunoCAP® Rapid</td><td>same</td></tr><tr><td></td><td>System, is an in vitro semi-quantitative assay for measurement of allergen specific IgE to inhalant in heparinized human capillary whole blood, heparinized venous whole blood, or heparinized plasma. ImmunoCAP® Rapid System consists of the</td><td>same</td></tr><tr><td></td><td>ImmunoCAP® Rapid</td><td></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Reader, ImmunoCAP®Rapid Reader Checkdevice, ImmunoCAP®Rapid Inhalant Profile 1,and ImmunoCAPRapidQC 1.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Reader Functionalities</td><td colspan="1" rowspan="1">The Reader is a standalone instrument to beused with ImmunoCAPRapid Assay Device. Theuser interface consists ofa LCD display with atouch screen and a slot forinsertion of theImmunoCAP RapidAssay Device.</td><td colspan="1" rowspan="1">same</td></tr><tr><td colspan="1" rowspan="1">Analysis of assay resultsfrom a whole bloodsample</td><td colspan="1" rowspan="1">Performed in defaultmode by measuring colorsaturation of assay results</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Analysis of assay resultsfrom a QC/plasmasample</td><td colspan="1" rowspan="1">Performed in QC/plasmamode (after pressing theQC/plasma button) bymeasuring colorsaturation of assay results</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Reader performancecheck</td><td colspan="1" rowspan="1">Mandatory after 7 daysand is performed byinserting the CheckDevice</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Setting of date and time</td><td colspan="1" rowspan="1">Performed from Settingsmenu displayed on thetouch screen</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate</td></tr><tr><td colspan="1" rowspan="1">Reader hardwarecomponents</td><td colspan="1" rowspan="1">Hardware updatedReader</td><td colspan="1" rowspan="1">Hardware currentReader</td></tr><tr><td colspan="1" rowspan="1">Assay Device dockingsystem</td><td colspan="1" rowspan="1">One optical switch</td><td colspan="1" rowspan="1">Two mechanical switches</td></tr><tr><td colspan="1" rowspan="1">Light source</td><td colspan="1" rowspan="1">Four white colorspectrumLED's and four diffusers</td><td colspan="1" rowspan="1">Four white color spectrumLED's and two opticaldiffusers</td></tr><tr><td colspan="1" rowspan="1">Camera</td><td colspan="1" rowspan="1">CMOS camera with</td><td colspan="1" rowspan="1">CCD camera with</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">2048x1536 pixelresolution</td><td colspan="1" rowspan="1">1024x768pixel resolution</td></tr><tr><td colspan="1" rowspan="1">Computer system, harddisk</td><td colspan="1" rowspan="1">Microprocessor</td><td colspan="1" rowspan="1">Mini-PC</td></tr><tr><td colspan="1" rowspan="1">Power supply</td><td colspan="1" rowspan="1">45W input 100-240V ~1.2A50-60 Hz</td><td colspan="1" rowspan="1">65W input 100-240V ~1.6A50-60 Hz</td></tr><tr><td colspan="1" rowspan="1">Display and Touchscreen</td><td colspan="1" rowspan="1">LCD panel resolution480x272</td><td colspan="1" rowspan="1">LCD panel resolution640x480</td></tr><tr><td colspan="1" rowspan="1">Printer</td><td colspan="1" rowspan="1">Built-in thermo printer</td><td colspan="1" rowspan="1">Separate thermo printer</td></tr><tr><td colspan="1" rowspan="1">Weight and Footprint(WxDxH in mm)</td><td colspan="1" rowspan="1">1.0 kg237x117x147</td><td colspan="1" rowspan="1">5.8 kg214x178x252</td></tr><tr><td colspan="1" rowspan="1">Software Feature</td><td colspan="1" rowspan="1">Updated Reader Software</td><td colspan="1" rowspan="1">Current Reader Software</td></tr><tr><td colspan="1" rowspan="1">Printing of results</td><td colspan="1" rowspan="1">Automatic aftercompletion of analysis</td><td colspan="1" rowspan="1">User initiated printing</td></tr><tr><td colspan="1" rowspan="1">Programming language</td><td colspan="1" rowspan="1">C and C++</td><td colspan="1" rowspan="1">C and Octave</td></tr><tr><td colspan="1" rowspan="1">Settingup/communicatingwith peripheralcomponents, handle filesystems, signals and taskscheduling</td><td colspan="1" rowspan="1">Linux kernel 2.6.22.6</td><td colspan="1" rowspan="1">Linux kernel 2.6.20</td></tr><tr><td colspan="1" rowspan="1">Set up RAM, CPUregisters and clocks, andstart Linux kernel</td><td colspan="1" rowspan="1">Redboot</td><td colspan="1" rowspan="1">BIOS (Basic input/outputsystem) in PC</td></tr><tr><td colspan="1" rowspan="1">Framework for GraphicalUser Interface.</td><td colspan="1" rowspan="1">Qt</td><td colspan="1" rowspan="1">GTK+ and Cairo</td></tr><tr><td colspan="1" rowspan="1">Library to convert toprinter data format</td><td colspan="1" rowspan="1">Ghostscript</td><td colspan="1" rowspan="1">CUPS</td></tr></table>

# I. Special Control/Guidance Document Referenced (if applicable):

CLSI EP17- Protocols for Determination of Limits of Detection and Limits of   
Quantitation   
Guidance for the Content of Premarket Submissions for Software Contained in   
Medical Devices - Guidance for Industry and FDA Staff   
Radioallergosorbent Test (RAST) Methods for Allergen-Specific Immunoglobulin E   
(IgE) 510(k)s; Final Guidance for Industry and FDA

J. Performance Characteristics:

1. Analytical Performance: a. Method Comparison: The performance of the Reader in reading the level of IgE antibodies to each of ten allergens (house dust mite, cat, dog, mold, and pollen from common ragweed, Bermuda grass, timothy grass, oak, and elm) was compared to the predicate device and agreement between the two methods was assessed. The comparison study shows that the new device is in agreement with the predicate device when measuring IgE levels in either whole blood or plasma.

i) Whole Blood Comparison Study: Heparinized capillary whole blood was collected from 134 donors. Each sample was tested with one ImmunoCAP Rapid Inhalant Profile 1 Assay Device according to Directions for Use. After completion of the assay, each Assay Device was read in both the New and the Predicate Device.

New Device compared to Predicate Device using whole blood samples.   

<table><tr><td rowspan=1 colspan=1>Allergen</td><td rowspan=1 colspan=1>NPA%</td><td rowspan=1 colspan=1>Lower95% CI%</td><td rowspan=1 colspan=1>Upper95% CI%</td><td rowspan=1 colspan=1>PPA%</td><td rowspan=1 colspan=1>Lower95% CI%</td><td rowspan=1 colspan=1>Upper95% CI%</td><td rowspan=1 colspan=1>Overallagreement%</td><td rowspan=1 colspan=1>NumberOfmeasurements</td></tr><tr><td rowspan=1 colspan=1>e1</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>89</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>d1</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>91</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>g2</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>w1</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>92</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>t7</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>m6</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>87</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>g6</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>92</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>t8</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>92</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>e5</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>92</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>91</td><td rowspan=1 colspan=1>78</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>d2</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>89</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>134</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>1340</td></tr></table>

ii. Plasma Comparison Study: In-house plasma samples from 239 sensitized donors with measurable specific IgE levels to one or more of the allergens in ImmunoCAP Rapid Inhalant Profile 1. All samples were run according to ImmunoCAP Rapid Inhalant Profile 1 Directions for Use. After completion of the assay, each Assay Device was read in both the New and the Predicate Device.

New Device compared to Predicate Device using plasma samples.   

<table><tr><td colspan="1" rowspan="1">Allergen</td><td colspan="1" rowspan="1">NPA%</td><td colspan="1" rowspan="1">Lower95% CI%</td><td colspan="1" rowspan="1">Upper95% CI%</td><td colspan="1" rowspan="1">PPA%</td><td colspan="1" rowspan="1">Lower95% CI%</td><td colspan="1" rowspan="1">Upper95% CI%</td><td colspan="1" rowspan="1">Overallagreement%</td><td colspan="1" rowspan="1">Numberofmeasurements</td></tr><tr><td colspan="1" rowspan="1">e1</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">92</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">d1</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">96</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">g2</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">w1</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">96</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">t7</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">96</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">m6</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">94</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">g6</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">t8</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">e5</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">92</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">d2</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">891</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">239</td></tr><tr><td colspan="1" rowspan="1">All</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">96</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">97</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">2390</td></tr></table>

# b. Precision/Reproducibility:

The sponsor performed a precision study using a special pre-prepared Assay Device to estimate the variation within and between Readers. The Assay Device was constructed using the same plastic housing device as in ImmunoCAP Rapid Inhalant Profile 1, but replacing the allergen strips with pre-prepared strips with 5 defined colored areas. The same pre-prepared Assay Device was read by 3 different Readers in 30 replicates. The Color Units (CU) values were recorded for each reading and the variation within and between Readers was estimated using a one-way analysis of variance model and the estimated components expressed as $C V \%$ .

Table below show the Coefficients Variance $( \mathrm { C V \% } )$ for a pre-colored Assay Device read in 3 different Readers in 30 replicates and measured as Color Units (CU). As shown in the table below, $\%$ CV between readers varied from 0.46 to 2.69 and within readers varied from 0.3 to 2.43. The total $C V \%$ varied from 0.59 to 3.63.

<table><tr><td colspan="1" rowspan="1">Line</td><td colspan="1" rowspan="1">Correspondingallergenposition</td><td colspan="1" rowspan="1">Number ofReadings</td><td colspan="1" rowspan="1">CUMean</td><td colspan="1" rowspan="1">CV%BetweenReaders</td><td colspan="1" rowspan="1">CV%WithinReaders</td><td colspan="1" rowspan="1">CV%Total</td><td colspan="1" rowspan="1">CV%Total</td></tr><tr><td colspan="1" rowspan="1">Left 1</td><td colspan="1" rowspan="1">e1</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">24.02</td><td colspan="1" rowspan="1">1.09</td><td colspan="1" rowspan="1">0.41</td><td colspan="1" rowspan="1">1.06</td><td colspan="1" rowspan="1">1.06</td></tr><tr><td colspan="1" rowspan="1">Left 2</td><td colspan="1" rowspan="1">d1</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">11.92</td><td colspan="1" rowspan="1">0.81</td><td colspan="1" rowspan="1">0.42</td><td colspan="1" rowspan="1">0.59</td><td colspan="1" rowspan="1">0.59</td></tr><tr><td colspan="1" rowspan="1">Left 3</td><td colspan="1" rowspan="1">g2</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">7.64</td><td colspan="1" rowspan="1">0.75</td><td colspan="1" rowspan="1">0.40</td><td colspan="1" rowspan="1">0.91</td><td colspan="1" rowspan="1">0.91</td></tr><tr><td colspan="1" rowspan="1">Left 4</td><td colspan="1" rowspan="1">w1</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">2.74</td><td colspan="1" rowspan="1">0.97</td><td colspan="1" rowspan="1">0.78</td><td colspan="1" rowspan="1">1.14</td><td colspan="1" rowspan="1">1.14</td></tr><tr><td colspan="1" rowspan="1">Left 5</td><td colspan="1" rowspan="1">t7</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">0.57</td><td colspan="1" rowspan="1">0.74</td><td colspan="1" rowspan="1">2.29</td><td colspan="1" rowspan="1">3.63</td><td colspan="1" rowspan="1">3.63</td></tr><tr><td colspan="1" rowspan="1">Right 1</td><td colspan="1" rowspan="1">m6</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">23.27</td><td colspan="1" rowspan="1">1.01</td><td colspan="1" rowspan="1">0.30</td><td colspan="1" rowspan="1">1.16</td><td colspan="1" rowspan="1">1.16</td></tr><tr><td colspan="1" rowspan="1">Right 2</td><td colspan="1" rowspan="1">g6</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">11.89</td><td colspan="1" rowspan="1">0.46</td><td colspan="1" rowspan="1">0.37</td><td colspan="1" rowspan="1">0.91</td><td colspan="1" rowspan="1">0.91</td></tr><tr><td colspan="1" rowspan="1">Right 3</td><td colspan="1" rowspan="1">t8</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">7.42</td><td colspan="1" rowspan="1">0.81</td><td colspan="1" rowspan="1">0.42</td><td colspan="1" rowspan="1">0.85</td><td colspan="1" rowspan="1">0.85</td></tr><tr><td colspan="1" rowspan="1">Right 4</td><td colspan="1" rowspan="1">e5</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">2.72</td><td colspan="1" rowspan="1">0.92</td><td colspan="1" rowspan="1">0.68</td><td colspan="1" rowspan="1">1.25</td><td colspan="1" rowspan="1">1.25</td></tr><tr><td colspan="1" rowspan="1">Right 5</td><td colspan="1" rowspan="1">d2</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">0.58</td><td colspan="1" rowspan="1">2.69</td><td colspan="1" rowspan="1">2.43</td><td colspan="1" rowspan="1">2.41</td><td colspan="1" rowspan="1">2.41</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">1.18</td><td colspan="1" rowspan="1">1.15</td><td colspan="1" rowspan="1">1.64</td><td colspan="1" rowspan="1">1.64</td></tr></table>

c. Linearity: Not applicable.   
d. Carryover: Not applicable (This device does not come into contact with analytical samples.)   
e. Interfering Substances: Not applicable (Interfering substances are a property of the Assay Device and not the Reader.)

2. Other Supportive Instrument Performance Data Not Covered Above:

Limit of Blank/Limit of Detection (LoD and LoB for each allergen and total)

<table><tr><td rowspan=1 colspan=1>Allergen</td><td rowspan=1 colspan=1>LoB(MeanCU)</td><td rowspan=1 colspan=1>LoD(MeanCU)</td></tr><tr><td rowspan=1 colspan=1>e1</td><td rowspan=1 colspan=1>0.056</td><td rowspan=1 colspan=1>0.073</td></tr><tr><td rowspan=1 colspan=1>d1</td><td rowspan=1 colspan=1>0.192</td><td rowspan=1 colspan=1>0.256</td></tr><tr><td rowspan=1 colspan=1>g2</td><td rowspan=1 colspan=1>0.086</td><td rowspan=1 colspan=1>0.123</td></tr><tr><td rowspan=1 colspan=1>w1</td><td rowspan=1 colspan=1>0.112</td><td rowspan=1 colspan=1>0.159</td></tr><tr><td rowspan=1 colspan=1>t7</td><td rowspan=1 colspan=1>0.106</td><td rowspan=1 colspan=1>0.146</td></tr><tr><td rowspan=1 colspan=1>m6</td><td rowspan=1 colspan=1>0.129</td><td rowspan=1 colspan=1>0.181</td></tr><tr><td rowspan=1 colspan=1>g6</td><td rowspan=1 colspan=1>0.085</td><td rowspan=1 colspan=1>0.123</td></tr><tr><td rowspan=1 colspan=1>t8</td><td rowspan=1 colspan=1>0.092</td><td rowspan=1 colspan=1>0.129</td></tr><tr><td rowspan=1 colspan=1>e5</td><td rowspan=1 colspan=1>0.077</td><td rowspan=1 colspan=1>0.107</td></tr><tr><td rowspan=1 colspan=1>d2</td><td rowspan=1 colspan=1>0.118</td><td rowspan=1 colspan=1>0.157</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>0.131</td><td rowspan=1 colspan=1>0.183</td></tr></table>

Comparison of total LoB and total LoD as measured by New and Predicate Device

<table><tr><td rowspan=1 colspan=1>Reader</td><td rowspan=1 colspan=1>LoB (CU)Mean</td><td rowspan=1 colspan=1>LoB (CU)95thPercentile</td><td rowspan=1 colspan=1>LoD (CU)Mean</td><td rowspan=1 colspan=1>LoD (CU)95th Percentile</td></tr><tr><td rowspan=1 colspan=1>New device</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.18</td><td rowspan=1 colspan=1>0.20</td></tr><tr><td rowspan=1 colspan=1>Predicate device</td><td rowspan=1 colspan=1>0.16*</td><td rowspan=1 colspan=1>0.16*</td><td rowspan=1 colspan=1>0.22*</td><td rowspan=1 colspan=1>0.22*</td></tr></table>

\*Values from K081830

# K. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# L. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.